Home » Quasar 483 Notes a Lack of Vetting Procedures
Quasar 483 Notes a Lack of Vetting Procedures
Quasar Bio-Tech did not establish and implement procedures for the manufacture and in-process control of electronic devices made by its contract manufacturer, according to a recent Form 483. The Sarasota, Fla., company also had not conducted site audits or maintained a contractual agreement with the contractor to determine if it was processing Quasar’s electronic devices according to good manufacturing practices, the May 11 form says.
The GMP Letter
The GMP Letter
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May